NCT05284552 - Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Epithelial Ovarian Cancer

Interventions

DRUG

Tinzaparin Injectable Solution

Subcutaneous injection

Trial Locations (8)

33152

RECRUITING

Department of Obstetrics and Gynecology, Värnamo Hospital, Värnamo

41345

RECRUITING

Department of Oncology, Sahlgrenska University Hospital, Gothenburg

55305

RECRUITING

Department of Obstetrics and Gynecology, Ryhov County Hospital, Jönköping

58185

RECRUITING

Department of Oncology, Linköping University Hospital, Linköping

ACTIVE_NOT_RECRUITING

Department of Obstetrics and Gynecology, University Hospital, Linköping

90719

RECRUITING

Department of Obstetrics and Gynaecology, Norrland University Hospital, Umeå

575 81

RECRUITING

Department of Obstetrics and Gynecology, Highland Hospital, Eksjö

593 81

RECRUITING

Department of Obstetrics and Gynecology, Västervik Hospital, Västervik

All Listed Sponsors

collaborator

Region Jönköping County

OTHER_GOV

collaborator

Västervik Hospital

OTHER

collaborator

Vastra Gotaland Region

OTHER_GOV

collaborator

Region Västerbotten

OTHER_GOV

lead

University Hospital, Linkoeping

OTHER